Dermata Therapeutics, Inc. · NASDAQ:DRMA
Armistice Capital, LLC reported a 4.99% stake in Dermata Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Armistice Capital, LLC reported a 4.99% stake in Dermata Therapeutics, Inc., 53,910 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 53,910
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 4.99% | 53,910 |
| Steven Boyd | 4.99% | 53,910 |
Source
Related
- Dermata Therapeutics, Inc.
- Armistice Capital, LLC
- Dermata Therapeutics, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Feb 18, 2026
- Form 4 · Proehl Gerald T · Aug 18, 2026
- Form 4 · Van Hoose Kyri K. · Aug 18, 2026
- Form 4 · Scott Kathleen D. · Jun 16, 2026
- Schedule 13D · Van Hoose Kyri K. · Jun 1, 2026
- Schedule 13G/A · Mitchell P. Kopin · May 13, 2026